Wealth Alliance’s BioRestorative Therapies BRTX Stock Holding History

Wealth Alliance’s Portfolio BRTX Stock Details BRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15K	Hold	40,000	–	–	﹤0.01%	572
2026 Q1	$10.9K	Hold	40,000	–	–	﹤0.01%	548
2025 Q4	$47K	Hold	40,000	–	–	﹤0.01%	548
2025 Q3	$58K	Hold	40,000	–	–	0.01%	547
2025 Q2	$66.6K	Hold	40,000	–	–	0.01%	536
2025 Q1	$71.2K	Hold	40,000	–	–	0.01%	509
2024 Q4	$57.2K	Hold	40,000	–	–	0.01%	489
2024 Q3	$69.6K	Hold	40,000	–	–	0.01%	516
2024 Q2	$81.2K	Hold	40,000	–	–	0.01%	504
2024 Q1	$55.2K	Hold	40,000	–	–	0.01%	511
2023 Q4	$69.6K	Hold	40,000	–	–	0.01%	503
2023 Q3	$71.6K	Sell	40,000 -4,316	-10%	-$10.9K	0.01%	480
2023 Q2	$195K	Hold	44,316	–	–	0.03%	482
2023 Q1	$151K	Hold	44,316	–	–	0.02%	483
2022 Q4	$122K	Hold	44,316	–	–	0.02%	474
2022 Q3	$143K	Hold	44,316	–	–	0.03%	430
2022 Q2	$131K	Buy	44,316 +4,316	+11%	+$18.3K	0.03%	423
2022 Q1	$209K	Hold	40,000	–	–	0.04%	419
2021 Q4	$174K	Buy	+40,000	New	+$228K	0.04%	432

Other funds holding BRTX

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

KFGK

Keystone Financial Group (Kentucky) Lexington, Kentucky $1.69B AUM 40.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wealth Alliance's BRTX Position: Q2 2026 in Review

Wealth Alliance held its BioRestorative Therapies (BRTX) position steady in Q2 2026 at 40,000 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #572.

Wealth Alliance first reported a position in BRTX in Q4 2021 and has held it in 19 quarters since. The position peaked at $209K in Q1 2022. 21 funds tracked by Wall St. Rank hold BRTX as of Q2 2026.

Wealth Alliance held 40,000 shares of BioRestorative Therapies worth $15K as of Q2 2026.
Wealth Alliance left its BioRestorative Therapies share count unchanged in Q2 2026.
BioRestorative Therapies made up ﹤0.01% of Wealth Alliance's portfolio in Q2 2026, its #572 holding.
Wealth Alliance first reported a position in BioRestorative Therapies in Q4 2021 and has held it in 19 quarters since.
Wealth Alliance's BioRestorative Therapies position peaked at $209K in Q1 2022.
21 funds tracked by Wall St. Rank held BioRestorative Therapies as of Q2 2026.

Based on Wealth Alliance's 13F filing for Q2 2026, filed 11 Aug 2026.